Citation: | ZENG Ye, ZHOU Zixuan, SUN Xun. Preparation of sheddable PEG modified miRNA-complexing nanoparticles and its preliminary in vitro and in vivo study[J]. Journal of China Pharmaceutical University, 2016, 47(6): 702-707. DOI: 10.11665/j.issn.1000-5048.20160612 |
[1] |
Bartel DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
|
[2] |
Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way[J].Cell,2009,136(4):586-591.
|
[3] |
Zhu L,Mahato RI.Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation[J].Bioconjug Chem,2010,21(11):2119-2127.
|
[4] |
Li FY,Zhou JP,Wu XM,et al.Formula optimization and transfection efficiency of polyethyleneimine/DNA complexes[J].J China Pharm Univ(中国药科大学学报),2010,41(1):40-44.
|
[5] |
Dash PR, Read ML, Barrett LB, et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].Gene Ther,1999,6(4):643-650.
|
[6] |
Caplen NJ.Gene therapy progress and prospects.Downregulating gene expression:the impact of RNA interference [J].Gene Ther,2004,11(16):1241-1248.
|
[7] |
Vile RG,Russell SJ,Lemoine NR.Cancer gene therapy:hard lessons and new courses [J].Gene Ther,2000,7(7):2-8.
|
[8] |
Li YH,Zong L,Zhu JB,et al.Formulation optimization of PEGylated cationic liposomes as siRNA delivery system [J].J China Pharm Univ(中国药科大学学报),2011,42(5):412-417.
|
[9] |
Mishra S, Webster P, Davis ME, et al. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles [J].Eur J Cell Biol,2004,83(3):97-111.
|
[10] |
Pun SH,Bellocq NC,Liu A,et al.Cyclodextrin-modified polyethylenimine polymers for gene delivery [J].Bioconjug Chem,2004,15(4):831-840.
|
[11] |
Larsen KL,Endo T,Ueda H,et al.Inclusion complex formation constants of α-,β-,γ-,δ-,ε-,ζ-,η- and θ-cyclodextrins determined with capillary zone electrophoresis [J].Carbohydr Res,1998,309(309):153-159.
|
[1] | XIA Yuan, JIANG Qingling, WANG Xiaoting, LI Minjing, ZHENG Qiusheng, LI Defang. Norcantharidin induces apoptosis through autophagosome accumulation in breast cancer MDA-MB-231 cells[J]. Journal of China Pharmaceutical University, 2023, 54(6): 757-768. DOI: 10.11665/j.issn.1000-5048.2023033004 |
[2] | XU Lingya, LIU Xue, CAO Xiaoyang, ZHANG Xinyi, YAO Jing, WANG Chuangong. Effect of ACE2 on the prognosis of breast cancer and its potential mechanism[J]. Journal of China Pharmaceutical University, 2023, 54(5): 586-598. DOI: 10.11665/j.issn.1000-5048.2023033102 |
[3] | WANG Kaizhen, YANG Wanwan, XU Shengyao, GUO Qinglong, ZHAO Li. Effects and mechanisms of AKR1C3 inducing doxorubicin resistance in breast cancer[J]. Journal of China Pharmaceutical University, 2021, 52(3): 352-360. DOI: 10.11665/j.issn.1000-5048.20210313 |
[4] | QIAN Sijia, YIN Jun, YAO Wenbing, GAO Xiangdong. Research progress of breast cancer metabolic reprogramming and microenvironment remodeling[J]. Journal of China Pharmaceutical University, 2021, 52(2): 156-163. DOI: 10.11665/j.issn.1000-5048.20210203 |
[5] | YAN Liang, ZAN Jiawei, FENG Zunyong, MA Jinzhu, XU Lei, WANG Yi. Dipyridyl pyrrolidine inhibits MDA-MB231 breast cancer cell cycle by inhibiting AKT-mTOR[J]. Journal of China Pharmaceutical University, 2018, 49(6): 718-824. DOI: 10.11665/j.issn.1000-5048.20180613 |
[6] | WU You, TANG Tingting, ZHU Qinhua, JIN Liang, PAN Yi. Mechanisms of miR-29a in migration and invasion of breast cancer MCF-7 cells in vitro[J]. Journal of China Pharmaceutical University, 2018, 49(3): 348-353. DOI: 10.11665/j.issn.1000-5048.20180314 |
[7] | GU Yi, LI Xiaoman, ZHENG Lufeng, YANG Jue, XI Tao. MicroRNA-10b regulates proliferation, cell cycle and apoptosis in human breast cancer cells[J]. Journal of China Pharmaceutical University, 2015, 46(2): 242-249. DOI: 10.11665/j.issn.1000-5048.20150218 |
[8] | HE Zhenhui, HE Taiping, WENG Shanfan, HUANG Yuequn, QIN Yanmei, Liang Nianci. Inhibitory effect of the diterperoid compound 5F isolated from Pteris semipinnata L.on breast cancer growth and metastasis in vivo[J]. Journal of China Pharmaceutical University, 2014, 45(1): 92-96. DOI: 10.11665/j.issn.1000-5048.20140117 |
[9] | HU Shan, DENG Yongchuan. Mechanism of isorhamnetin on breast cancer cells[J]. Journal of China Pharmaceutical University, 2013, 44(6): 563-567. DOI: 10.11665/j.issn.1000-5048.20130615 |
[10] | LIN Sensen, WANG Congpin, WAN Shuying, SUN Li, YUAN Shengtao, ZHANG Luyong. Effect of inhibiting CC chemokine receptor 5 on human breast cancer cell adhesion and migration[J]. Journal of China Pharmaceutical University, 2013, 44(4): 362-367. DOI: 10.11665/j.issn.1000-5048.20130415 |